Parties Debate Adequacy of GLP-1 Label Warnings On April 9, lawyers representing the drug makers and plaintiffs involved in the litigation each submitted position papers to Judge Pratter, explaining their differing opinions on the litigation, which will largely focus on whether the label warnings for Ozempic, Mounjaro, Wegovy and Zepbound adequately disclosed the risks of gastroparesis and other intestinal injuries
Blue Cross Blue Shield of Michigan and Blue Care Network GLP-1 Update On June 6, 2024, Blue Cross Blue Shield of Michigan and Blue Care Network announced they plan to change the criteria for coverage of GLP-1 obesity drugs, including Wegovy, Saxenda and Zepbound effective August 1, 2024
2.2.1 URAT1 URAT1 stands as a pivotal apical urate exchanger within the proximal renal tubules, wielding a central role in the intricate physiological homeostasis of urate [54]
For optimal chromium benefits, consistent daily supplementation is recommended, ideally taken with meals to enhance absorption
It is a playful name for a serious protocol, and it stuck because patients keep coming back for it